Evaluation of oral pregabalin administration on pain of patients undergoing prostate biopsy
Phase 3
Recruiting
- Conditions
- Prostate cancer.Malignant neoplasm of prostate
- Registration Number
- IRCT20200205046388N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 52
Inclusion Criteria
Male patients with PSA =4.0 ng/mL
Lithotomy position for prostate biopsy is possible for participants
Exclusion Criteria
Prior pelvic pain before prostate biopsy
TURP history
Hormonal therapy or radiotherapy history
Existing any Ano-rectal pathology
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method